Computational assessment of the use of graphene-based nanosheets as PtII chemotherapeutics delivery systems

© 2024 Wiley Periodicals LLC.

Bibliographische Detailangaben
Veröffentlicht in:Journal of computational chemistry. - 1984. - 45(2024), 24 vom: 15. Juli, Seite 2059-2070
1. Verfasser: Belletto, Daniele (VerfasserIn)
Weitere Verfasser: Vigna, Vincenzo, Barretta, Pierraffaele, Ponte, Fortuna, Mazzone, Gloria, Scoditti, Stefano, Sicilia, Emilia
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2024
Zugriff auf das übergeordnete Werk:Journal of computational chemistry
Schlagworte:Journal Article DFT PtII drugs adsorption energy drug delivery graphene‐based carriers Graphite 7782-42-5 Antineoplastic Agents Cisplatin mehr... Q20Q21Q62J Drug Carriers Carboplatin BG3F62OND5 Oxaliplatin 04ZR38536J Organoplatinum Compounds
Beschreibung
Zusammenfassung:© 2024 Wiley Periodicals LLC.
Graphene is the newest form of elemental carbon and it is becoming rapidly a potential candidate in the framework of nano-bio research. Many reports confirm the successful use of graphene-based materials as carriers of anticancer drugs having relatively high loading capacities compared with other nanocarriers. Here, the outcomes of a systematic study of the adsorption behavior of FDA approved PtII drugs cisplatin, oxaliplatin, and carboplatin on surface models of pristine, holey, and nitrogen-doped holey graphene are reported. DFT investigations in water solvent have been carried out considering several initial orientations of the drugs with respect to the surfaces. Adsorption free energies, calculated including basis set superposition error (BSSE) corrections, result to be significantly negative for many of the drugcarrier adducts indicating that tested layers could be used as potential carriers for the delivery of anticancer PtII drugs. The reduced density gradient (RDG) analysis allows to show that many kinds of non-covalent interactions, including canonical H-bond, are responsible for the stabilization of the formed adducts
Beschreibung:Date Completed 16.07.2024
Date Revised 16.07.2024
published: Print-Electronic
Citation Status MEDLINE
ISSN:1096-987X
DOI:10.1002/jcc.27394